Shortcomings and future perspectives of antiviral drugs in Covid-19
A video interview with a researcher expert in respiratory viruses features the state-of-the-art of antiviral research and the work to improve their efficacy
Published on
30 Nov 2022
A video interview with a researcher expert in respiratory viruses features the state-of-the-art of antiviral research and the work to improve their efficacy
Antiviral drugs are one of the currently available tools to reduce the complications of Covid-19 infections, as they act by blocking the mechanisms of virus reproduction.
We asked Valeria Cagno, Group Leader at the Institute of Microbiology of the University of Lausanne (Switzerland) and the University Hospital of Lausanne, to shed some light on this topic and to explain which antiviral drugs are currently available, what the current problems are, and what the future use and perspectives can be.
